Long Peripheral Intravenous Catheter Insertion Site and Catheter-related Complications in Antimicrobial Therapy
Launched by SIR RUN RUN SHAW HOSPITAL · Jun 6, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of long peripheral intravenous catheters (PIVCs) in patients who are receiving antimicrobial therapy, which is a type of treatment to fight infections. The researchers want to find out if the placement of these catheters in different locations on the body affects complications, such as discomfort or infections. The goal is to help patients choose the best site for catheter placement, which could lead to fewer problems and a more comfortable experience during their treatment.
To participate in this study, you need to be at least 18 years old and expected to receive intravenous (IV) treatments for at least a week while in the hospital. You should be able to communicate normally and have no previous issues at the catheter insertion site, like trauma or blood clots. If you join the trial, you will have the catheter placed, and researchers will monitor your experience to help improve care for future patients. This study is currently recruiting participants, and anyone interested should consult with their healthcare provider for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ① estimated time of intravenous infusion ≥1 week; ② age: ≥18 years; ③ antimicrobial therapy was only used for treatment during hospitalization, with a pH value of 5-9 and osmotic pressure \< 900 mOsm/L; and ④ patients were conscious and able to communicate normally; ⑤ the catheter-to-vessel ratio is less than 45%.
- Exclusion Criteria:
- • ① a history of radiotherapy, thrombosis, and trauma at the catheterization site and ② plans to discharge with a catheter during the study duration.
About Sir Run Run Shaw Hospital
Sir Run Run Shaw Hospital is a distinguished medical institution dedicated to advancing healthcare through innovative clinical research and high-quality patient care. As a leading sponsor of clinical trials, the hospital integrates state-of-the-art medical technology with a commitment to ethical standards and patient safety. With a multidisciplinary team of experienced healthcare professionals, Sir Run Run Shaw Hospital focuses on a wide range of therapeutic areas, aiming to contribute to medical knowledge and improve treatment outcomes. The institution fosters collaboration with academic and industry partners to drive scientific discovery and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, , China
Patients applied
Trial Officials
Zhao Linfang
Principal Investigator
Sir Run Run Shaw Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported